Associated Papers
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N et al.
American Journal of Hematology, 2024
Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
Yin B et al.
Hematology (amsterdam, Netherlands), 2019
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
30053901 (PubMed )
Supplement: 13073_2018_564_MOESM2_ESM.xlsx › 3
Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N et al.
Blood Cancer Journal, 2018
Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.
Zhang H et al.
Leukemia, 2017
Chronic neutrophilic leukemia: a clinical perspective.
Menezes J et al.
Oncotargets and Therapy, 2015
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
Maxson JE et al.
The Journal of Biological Chemistry, 2014
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Maxson JE et al.
The New England Journal of Medicine, 2013
Select a paper to view details